Background: While there has been a global decline in maternal deaths, South Africa has seen a reversal in gains with an increase in the maternal mortality ratio in the past decade. Published data up to 2010 indicate that HIV-related infections remain the leading cause of maternal deaths in South Africa. The data do not reflect the impact of increased antiretroviral therapy (ART) coverage, and increase in CD4 threshold for pregnant women to 350 cells/mm3, since 2010. Methodology: We assessed trends in maternal deaths over a 15-year period, 1997-2012, in a district referral hospital in Johannesburg, South Africa. The hospital has approximately 22 000 deliveries per annum, with about a third of pregnant women HIV-infected. It is part of a relatively well-functioning prevention of mother-to-child transmission (PMTCT) programme, where transmission rates have decreased to between 2% and 3% in the past decade. Time trends were analysed by comparing the number of maternal deaths; patterns in HIV-related deaths; and diagnosis and management of HIV disease in pregnant women, over four time periods. The periods coincide with major guideline changes in South Africa – Table 1. Results: During the 15-year period, there were 590 maternal deaths in the hospital. Overall, HIV-related infections were the leading cause of maternal mortality, accounting for 37.8% of all deaths, followed by hypertension (17.5%) and obstetric haemorrhage (13.4%). Of the women who died, 20.5% had not accessed antenatal care, while 11.9% had no documented records of antenatal care. The majority of deaths occurred postpartum – 470/590 (79.7%), and HIV-related deaths increased between 2003 and 2008, and have remained stable around 40%. Out of a total of 284 HIV-infected women who died, 66 (23.2%) had documented initiation of antiretrovirals (ARVs). Of those that had a CD4 count done, 74.6% had a ≤200 cells/mm3. Conclusions: In this review up to the end of 2012, HIV-related infections remained the leading cause of maternal deaths, despite the availability of efficacious ARVs. While HIV diagnosis during pregnancy improved, the majority of HIV-infected women who died were ART-eligible, and died without being started on ART. These findings are similar to national reports prior to the widespread availability of ART. In South Africa, gains made in PMTCT are not reflected in maternal mortality rates – targeted antenatal and postpartum interventions are needed if we are to decrease HIV-related maternal deaths.